Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathrin Fenner

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
Environmental Science and Pollution Research International|June 11, 2013
Response to comment of Sierra Rayne on "Targeting aquatic microcontaminants for monitoring: exposure categorization and application to the Swiss situation [Götz et al., Environ Sci Pollut Res (2010) 17:341-354]"Christian W Götz, Kathrin Fenner, Juliane Hollender
Environmental Science & Technology|August 19, 2007
Selecting scenarios to assess exposure of surface waters to veterinary medicines in EuropeManuel K Schneider, Christian Stamm, Kathrin Fenner
Environmental Science & Technology|September 8, 2020
Understanding the Dependence of Micropollutant Biotransformation Rates on Short-Term Temperature ShiftsPaola Meynet, Russell J Davenport, Kathrin Fenner
Environmental Science. Processes & Impacts|August 4, 2023
Combining predictive and analytical methods to elucidate pharmaceutical biotransformation in activated sludgeLeo Trostel, Claudia Coll, Kathrin Fenner, et al.
Environmental Science. Processes & Impacts|July 13, 2022
To be or not to be degraded: in defense of persistence assessment of chemicalsAndreas Schäffer, Kathrin Fenner, Zhanyun Wang, et al.
Water Research|May 12, 2023
From market to environment - consumption-normalised pharmaceutical emissions in the Rhine catchmentLaura Varga, Kathrin Fenner, Heinz Singer, et al.
Water Research|March 8, 2022
Large-scale assessment of organic contaminant emissions from chemical and pharmaceutical manufacturing into Swiss surface watersSabine Anliker, Sergio Santiago, Kathrin Fenner, et al.
Environmental Science & Technology|September 20, 2023
Benchmarking the Persistence of Active Pharmaceutical Ingredients in River SystemsMark Honti, Márton Zsugyel, Carolin Seller, et al.
Environmental Science & Technology|April 12, 2002
Including transformation products into the risk assessment for chemicals: the case of nonylphenol ethoxylate usage in SwitzerlandKathrin Fenner, Cornelis Kooijman, Martin Scheringer, et al.
Environmental Science & Technology|November 13, 2020
Quantification of Active Ingredient Losses from Formulating Pharmaceutical Industries and Contribution to Wastewater Treatment Plant EmissionsSabine Anliker, Michael Patrick, Kathrin Fenner, et al.
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Environmental Science and Pollution Research International|June 11, 2013
Response to comment of Sierra Rayne on "Targeting aquatic microcontaminants for monitoring: exposure categorization and application to the Swiss situation [Götz et al., Environ Sci Pollut Res (2010) 17:341-354]"Christian W Götz, Kathrin Fenner, Juliane Hollender
Environmental Science & Technology|August 19, 2007
Selecting scenarios to assess exposure of surface waters to veterinary medicines in EuropeManuel K Schneider, Christian Stamm, Kathrin Fenner
Environmental Science & Technology|September 8, 2020
Understanding the Dependence of Micropollutant Biotransformation Rates on Short-Term Temperature ShiftsPaola Meynet, Russell J Davenport, Kathrin Fenner
Environmental Science. Processes & Impacts|August 4, 2023
Combining predictive and analytical methods to elucidate pharmaceutical biotransformation in activated sludgeLeo Trostel, Claudia Coll, Kathrin Fenner, et al.
Environmental Science. Processes & Impacts|July 13, 2022
To be or not to be degraded: in defense of persistence assessment of chemicalsAndreas Schäffer, Kathrin Fenner, Zhanyun Wang, et al.
Water Research|May 12, 2023
From market to environment - consumption-normalised pharmaceutical emissions in the Rhine catchmentLaura Varga, Kathrin Fenner, Heinz Singer, et al.
Water Research|March 8, 2022
Large-scale assessment of organic contaminant emissions from chemical and pharmaceutical manufacturing into Swiss surface watersSabine Anliker, Sergio Santiago, Kathrin Fenner, et al.
Environmental Science & Technology|September 20, 2023
Benchmarking the Persistence of Active Pharmaceutical Ingredients in River SystemsMark Honti, Márton Zsugyel, Carolin Seller, et al.
Environmental Science & Technology|April 12, 2002
Including transformation products into the risk assessment for chemicals: the case of nonylphenol ethoxylate usage in SwitzerlandKathrin Fenner, Cornelis Kooijman, Martin Scheringer, et al.
Environmental Science & Technology|November 13, 2020
Quantification of Active Ingredient Losses from Formulating Pharmaceutical Industries and Contribution to Wastewater Treatment Plant EmissionsSabine Anliker, Michael Patrick, Kathrin Fenner, et al.
Pageof 13